ALA 3.57% 14.5¢ arovella therapeutics limited

Ann: Half Yearly Report and Accounts, page-38

  1. 3,664 Posts.
    lightbulb Created with Sketch. 657
    you'd  probably have to say the company is in the hands of Andrew Curtis these days to land us all something big with a major. Looking at his CV he's got the goods. We've got the right man to get the job done. I don't think much else is going to get this thing cranking. You'd have to conclude that they've just got nothing at this point in time to Ann other than stuff that's just going to get all us pack of whinges back on the wagon bagging Carter once again about a lack of progress. He announces an update / he doesn't announce an update....nothing will change. 

    I don't reckon there's much more you can read into what is or what isn't happening.

    and Bucky trying to tell us all that theyve stuffed up the half yearlies.... No!  The numbers make perfect sense if your recall what happened with the rights issue and the convertible notes blah blah blah...
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.5¢
Change
0.005(3.57%)
Mkt cap ! $152.5M
Open High Low Value Volume
14.0¢ 14.5¢ 14.0¢ $212.8K 1.496M

Buyers (Bids)

No. Vol. Price($)
8 435513 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 9923 1
View Market Depth
Last trade - 15.45pm 06/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.